obesity drug news today glp-1 september 22 2025 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss Lilly hikes revenue forecasts on

Schedule this increase for your fifth semaglutide injection

Eli Lilly has received FDA approval for its new GLP-1 weight loss pill, Foundayo, which is expected to hit the market next week

The clinical significance of these interactions will be detailed in the prescribing information when orforglipron is approved, and is an important consideration for the many patients with obesity or type 2 diabetes who take multiple concurrent medications

Follow ICMR Guidelines: ICMR recommends no more than 45% of total calories should come from cereals and millets, with up to 15% from pulses, beans, and meat, and the rest from nuts, vegetables, fruits, and milk

Eligible patients entered run-in phase where any OAD other than metformin were stopped and patients were prescribed glargine